X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
eslicarbazepine acetate (226) 226
index medicus (182) 182
epilepsy (178) 178
humans (159) 159
clinical neurology (134) 134
antiepileptic drugs (127) 127
partial-onset seizures (120) 120
oxcarbazepine (107) 107
carbamazepine (94) 94
double-blind (92) 92
anticonvulsants - therapeutic use (90) 90
male (89) 89
seizures (88) 88
eslicarbazepine (87) 87
pharmacology & pharmacy (85) 85
adult (81) 81
female (72) 72
anticonvulsants (68) 68
efficacy (65) 65
pharmacokinetics (65) 65
dibenzazepines - therapeutic use (60) 60
anticonvulsants - adverse effects (59) 59
middle aged (58) 58
adults (53) 53
neurology (53) 53
safety (53) 53
epilepsy - drug therapy (52) 52
analysis (48) 48
epilepsies, partial - drug therapy (46) 46
animals (45) 45
treatment outcome (44) 44
adjunctive treatment (43) 43
neurosciences (41) 41
young adult (41) 41
drug therapy (40) 40
dibenzazepines - adverse effects (39) 39
lacosamide (39) 39
phase-iii (37) 37
anticonvulsants - administration & dosage (36) 36
drugs (36) 36
anticonvulsants - pharmacokinetics (35) 35
dose-response relationship, drug (35) 35
psychiatry (35) 35
tolerability (35) 35
aged (34) 34
dibenzazepines - administration & dosage (34) 34
adjunctive therapy (33) 33
adolescent (33) 33
carbamazepine - analogs & derivatives (31) 31
clinical trials (30) 30
dibenzazepines - pharmacokinetics (30) 30
anticonvulsants - pharmacology (29) 29
dibenzazepines - pharmacology (28) 28
lamotrigine (28) 28
seizures - drug therapy (28) 28
refractory epilepsy (27) 27
brivaracetam (26) 26
drug interactions (26) 26
antiepileptic drug (25) 25
convulsions & seizures (25) 25
double-blind method (25) 25
gated sodium-channels (25) 25
medical research (25) 25
open-label extension (25) 25
acetic acid (23) 23
medicine & public health (23) 23
metabolites (23) 23
bia 2-093 (22) 22
drug therapy, combination (22) 22
steady-state (22) 22
therapy (22) 22
chemistry, analytical (21) 21
dibenzazepines - blood (21) 21
levetiracetam (21) 21
placebo-controlled trial (21) 21
bia-2-093 (20) 20
randomized controlled-trial (20) 20
anticonvulsant (19) 19
antiepileptic agents (19) 19
monotherapy (19) 19
topiramate (19) 19
drug dosages (18) 18
gabapentin (18) 18
medicine, experimental (18) 18
mice (18) 18
perampanel (18) 18
pregabalin (18) 18
behavioral sciences (17) 17
retigabine (17) 17
zonisamide (17) 17
add-on (16) 16
care and treatment (16) 16
dosage and administration (16) 16
healthy-subjects (16) 16
long-term safety (16) 16
rufinamide (16) 16
stereoisomerism (16) 16
anticonvulsants - chemistry (15) 15
pharmacotherapy (15) 15
steady-state pharmacokinetics (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurologia, ISSN 0213-4853, 03/2014, Volume 29, Issue 2, pp. 94 - 101
Introduction: Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) and an analogue to carbamazepine (CBZ) and oxcarbazepine (OXC). In this study, we... 
Oxcarbazepine | Eslicarbazepine | Drug-resistant | Epilepsy | Carbamazepine
Journal Article
Journal of Pain, ISSN 1526-5900, 01/2018, Volume 19, Issue 1, pp. 1 - 9
Providers are being asked to decrease the emphasis and overutilization of long-term opioid therapy, but many are left without proper guidance on appropriate... 
Oxcarbazepine | adjunct therapy | chronic pain management | eslicarbazepine | sodium channel blockers | carbamazepine | DRUG | ENZYME-INDUCTION | CLINICAL PHARMACOKINETICS | NEUROSCIENCES | CLINICAL NEUROLOGY | NA(V)1.9 | DOUBLE-BLIND | TRIGEMINAL NEURALGIA | ESLICARBAZEPINE ACETATE | MUTATIONS
Journal Article
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 2014, Volume 7, Issue 2, pp. 144 - 147
Journal Article
Epilepsy Research, ISSN 0920-1211, 12/2019, Volume 158, p. 106216
To evaluate the impact of eslicarbazepine acetate (ESL) monotherapy on markers of bone and lipid metabolism. We conducted a post-hoc analysis of data pooled... 
Focal seizure | Serum lipids | Enzyme-inducing antiepileptic drug | CYP450 | Bone metabolism | Eslicarbazepine acetate
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 12/2019, Volume 101, p. 106574
Eslicarbazepine acetate (ESL) is a third-generation antiepileptic drug (AED) approved as monotherapy for partial-onset seizures in adults and as adjunctive... 
Prospective | Focal epilepsy | Observational study | Monotherapy | Clinical practice | Eslicarbazepine acetate
Journal Article
Neurologia, ISSN 0213-4853, 06/2018, Volume 33, Issue 5, pp. 290 - 300
Introduction: The objective of the EPICON Project is to develop a set of recommendations on how to adequately switch from carbamazepine (CBZ) and oxcarbazepine... 
Oxcarbazepine | Situations | Methodology | Drug switching | Eslicarbazepine acetate | Carbamazepine
Journal Article
Journal Article
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, ISSN 1997-7298, 2018, Volume 118, Issue 4, pp. 140 - 145
Journal Article
Expert review of neurotherapeutics, 07/2019, pp. 1 - 10
Introduction: Epilepsy is one of the most common neurological disorders. The goal of pharmacologic therapy remains complete freedom from seizures with minimal... 
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 09/2018, Volume 138, Issue 3, pp. 203 - 211
Journal Article